(19)
(11) EP 4 808 529 A1

(12)

(43) Date of publication:
23.09.2026 Bulletin 2026/39

(21) Application number: 24891944.1

(22) Date of filing: 13.11.2024
(51) International Patent Classification (IPC): 
A61K 31/00(2006.01)
A61K 9/20(2006.01)
 A61K 9/28(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/155; A61K 31/7048; A61K 9/2077; A61K 9/2054
 
C-Sets:
  1. A61K 31/7048, A61K 2300/00;
  2. A61K 31/155, A61K 2300/00;
(86) International application number:
PCT/TR2024/051331
(87) International publication number:
WO 2025/106049 (22.05.2025 Gazette 2025/21)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 15.11.2023 TR 2023015093

(71) Applicant: Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi
34467 Sariyer/Istanbul (TR)

(72) Inventors:
  • DUDE, Udaya Kumar
    34467 Sariyer/Istanbul (TR)
  • MUND, Manas Ranjan
    34467 Sariyer/Istanbul (TR)
  • ALDENIZ, Emre Erol
    34467 Sariyer/Istanbul (TR)
  • GÜNDAR, Mesut
    34467 Sariyer/Istanbul (TR)

   


(54) A PHARMACEUTICAL COMPOSITION COMPRISING EMPAGLIFLOZIN AND METFORMIN